The deal, if completed, could be announced as early as Monday. The deal would bring together two businesses whose sales have slowed since former big sellers lost patent protection and began facing lower-priced competition. In other pharmaceutical news: black box warnings, antibiotics, and biotech's burning questions.
from Kaiser Health News https://ift.tt/314jXK1
July 29, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
At Opioid Rehab Facilities, New Suicide Prevention Guidelines Are Rolling OutWhile some programs already screen for suicide and have fewer deaths, Michael Johnson, managing director for the Commission on Accreditation of Rehabilitation Facilities, said “Right now, there’s no real standards for suicide… Read More
Pharma Has Always Had A Stronghold In Maryland’s Capitol, But Recent Loss Reveals New WeaknessesMaryland lawmakers have passed a first-of-its kind law to create a state board that could cap payments for ultra-expensive prescription drugs, a victory advocates were thrilled to achieve. Pharma has been fighting tooth-and-n… Read More
Marjory Stoneman Douglas High School Failed To Heed Warning Signs Of Violence From Shooter, Parkland Families Say In LawsuitThe families of the victims filed lawsuits against both the high school and the sheriff's office alleging they were negligent when it came to protecting students' safety. from Kaiser Health News http://bit.ly/2KrQOoD … Read More
From The State Capitols: Raising Age For Tobacco Purchases; Increasing Mental Health Spending; Expanding Telemedicine Coverage; And MoreNews on the state legislatures comes from Iowa, Washington, Ohio, Connecticut and California. from Kaiser Health News http://bit.ly/2UQcBKK … Read More
Popular Fisher-Price Rock ‘N Play Sleeper May Be Recalled Over Safety IssuesThe Consumer Product Safety Commission says there's an issue with babies rolling over in the product and not being able to roll back to a safe position. The panel is considering asking the company to voluntarily recall the pr… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment